Sort
15,440 grants matching “organoids”
Convergent Drivers of Tumor Evolution at the Mitotic Spindle
$560,290Frank M Mason · Vanderbilt University Medical Center · R01 · FY2023 · CA
Production and progression of premalignant retinoblastoma lesions.
$560,197David Cobrinik · Children'S Hospital Of Los Angeles · R01 · FY2025 · CA
Production and progression of premalignant retinoblastoma lesions.
$560,196David Cobrinik · Children'S Hospital Of Los Angeles · R01 · FY2024 · CA
An organotypic model recapitulating colon cancer microenvironment and metastasis
$560,162Emina Hui-Na Huang · Cleveland Clinic Lerner Com-Cwru · U01 · FY2017 · CA
Verteporfin as a YAP/TAZ inhibitor for treatment of glioblastoma
$560,145Renee D Read · Emory University · R01 · FY2024 · NS
Tuft cell heterogeneity in function, lineage, and structure in ileal inflammatory disease
$560,104Ken S Lau · Vanderbilt University · R01 · FY2024 · DK
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens
$560,027Rosalie C Sears · Oregon Health & Science University · U01 · FY2020 · CA
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
$559,976Anirban Maitra · University Of Tx Md Anderson Can Ctr · U24 · FY2021 · CA
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
$559,976Anirban Maitra · University Of Tx Md Anderson Can Ctr · U24 · FY2020 · CA
Whole Genome Sequencing for Nephrotic Syndrome Discovery
$559,912Matthew Gordon Sampson · Boston Children'S Hospital · R01 · FY2021 · DK
Development of iPSCs for comparative genomics in primates
$559,888Yoav Gilad · University Of Chicago · R01 · FY2025 · HG
Development of iPSCs for comparative genomics in primates
$559,888Yoav Gilad · University Of Chicago · R01 · FY2024 · HG
Translational Epigenetics with XIST: Silencing Trisomy in Human Organoid and Mouse Models of Down Syndrome
$559,872Jeanne Bentley Lawrence · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · HD
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
$559,847David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
$559,847David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer
$559,783Leif W Ellisen · Massachusetts General Hospital · R01 · FY2025 · CA
Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer
$559,783Leif W Ellisen · Massachusetts General Hospital · R01 · FY2022 · CA
Refining iPSC-Based Spinal Cord Model Systems by Fabricating Developmentally Programmed Extracellular Matrix Cues
$559,496Evangelos Kiskinis · Northwestern University At Chicago · R01 · FY2024 · AG
Integrative and longitudinal multi-omic risk assessment in inflammatory bowel disease progression
$559,348Subra Kugathasan · Emory University · U01 · FY2025 · DK
Transcriptional Regulation of Lung Alveolar Regeneration
$559,288Edward E Morrisey · University Of Pennsylvania · R01 · FY2024 · HL
The role of PKM2 in dietary lipid absorption and fructose-induced obesity
$559,196Marcus Dasilva Goncalves · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · DK
Mechanisms of alteration of gastrointestinal physiology by gut microbes
$559,098Purna C Kashyap · Mayo Clinic Rochester · R01 · FY2024 · DK
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
$558,719Kenneth H. Yu · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
A conserved transcriptional cascade involved in brain overgrowth, social behavior and autism
$558,715Anthony J Wynshaw-Boris · Case Western Reserve University · R01 · FY2017 · MH
Type I IFN signaling during lung development in Down Syndrome
$558,694Soula Athanasia Danopoulos · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2025 · HL